Lisa Deschamps

Board Member at Reset Pharmaceuticals

Lisa Deschamps is a passionate leader who brings a track record serving patients and delivering growth far exceeding expectations. Ms. Deschamps has spent more than 17 years at Novartis, and has held various leadership positions including as SVP & Chief Business Officer of Novartis Gene Therapies. Ms. Deschamps was responsible for driving strategic planning, commercialization and business development of the extensive gene therapy portfolio within AveXis. She has played a key role in leading the exploration of inorganic growth opportunities and external partnerships. Ms. Deschamps received an M.B.A. in General Management from the NYU Stern School of Business.